Synjardy (empagliflozin/metformin)

pCPA File Number: 20959
Negotiation Status:
Concluded with an LOI
Indication(s):
Diabetes Mellitus, Type 2
Sponsor/Manufacturer:
Boehringer Ingelheim (Canada) Ltd. Ltee.
CADTH Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: